Literature DB >> 14708275

Appropriateness of thresholds currently used to describe influenza activity in England.

N L Goddard1, J Kyncl, J M Watson.   

Abstract

The timing and magnitude of influenza virus activity in England each winter remain unpredictable. Nevertheless, it is important to describe levels of activity in a timely manner, using defined 'threshold values'. This informs public health practitioners and the general public of the level of influenza virus circulation, and provides an indication of when sufficient activity is occurring in the community to warrant the use of antiviral drugs. Data presented here suggest that the current numerical thresholds, and their corresponding descriptions, are no longer appropriate for the levels of activity recently observed in England. Based on integrated clinical and virological data, we suggest alternative threshold values of 'baseline' activity (0-30/100,000 population), 'normal seasonal' activity (30-200/100,000) and 'epidemic' activity (> 200/100,000).

Entities:  

Mesh:

Year:  2003        PMID: 14708275

Source DB:  PubMed          Journal:  Commun Dis Public Health        ISSN: 1462-1843


  11 in total

1.  Timing of monoclonal antibody for seasonal RSV prophylaxis in the United Kingdom.

Authors:  N L Goddard; M C Cooke; R K Gupta; J S Nguyen-Van-Tam
Journal:  Epidemiol Infect       Date:  2006-06-06       Impact factor: 2.451

2.  Healthcare Information Systems to Assess Influenza Outbreaks: An analysis of the 2009 H1N1 Epidemic in Buenos Aires.

Authors:  S Figar; V Aliperti; E Salazar; C Otero; M Schpilberg; V Taliercio; P Otero; F González Bernaldo de Quirós
Journal:  Appl Clin Inform       Date:  2011-02-23       Impact factor: 2.342

3.  Real-time epidemic forecasting for pandemic influenza.

Authors:  I M Hall; R Gani; H E Hughes; S Leach
Journal:  Epidemiol Infect       Date:  2006-08-24       Impact factor: 2.451

4.  Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people.

Authors:  Ben G Armstrong; Punam Mangtani; Astrid Fletcher; Sari Kovats; Anthony McMichael; Sam Pattenden; Paul Wilkinson
Journal:  BMJ       Date:  2004-08-15

5.  Rapid detection of pandemic influenza in the presence of seasonal influenza.

Authors:  Brajendra K Singh; Nicholas J Savill; Neil M Ferguson; Chris Robertson; Mark Ej Woolhouse
Journal:  BMC Public Health       Date:  2010-11-24       Impact factor: 3.295

Review 6.  Harmonizing influenza primary-care surveillance in the United Kingdom: piloting two methods to assess the timing and intensity of the seasonal epidemic across several general practice-based surveillance schemes.

Authors:  H K Green; A Charlett; J Moran-Gilad; D Fleming; H Durnall; D Rh Thomas; S Cottrell; B Smyth; C Kearns; A J Reynolds; G E Smith; A J Elliot; J Ellis; M Zambon; J M Watson; J McMenamin; R G Pebody
Journal:  Epidemiol Infect       Date:  2014-07-15       Impact factor: 4.434

7.  Tracking the spatial diffusion of influenza and norovirus using telehealth data: a spatiotemporal analysis of syndromic data.

Authors:  Duncan L Cooper; Gillian E Smith; Martyn Regan; Shirley Large; Peter P Groenewegen
Journal:  BMC Med       Date:  2008-06-26       Impact factor: 8.775

8.  The Relationship Between School Holidays and Transmission of Influenza in England and Wales.

Authors:  Charlotte Jackson; Emilia Vynnycky; Punam Mangtani
Journal:  Am J Epidemiol       Date:  2016-10-15       Impact factor: 4.897

9.  Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes.

Authors:  Eszter P Vamos; Utz J Pape; Vasa Curcin; Matthew J Harris; Jonathan Valabhji; Azeem Majeed; Christopher Millett
Journal:  CMAJ       Date:  2016-07-25       Impact factor: 8.262

10.  Occurrence of invasive pneumococcal disease and number of excess cases due to influenza.

Authors:  Katarzyna Grabowska; Liselotte Högberg; Pasi Penttinen; Ake Svensson; Karl Ekdahl
Journal:  BMC Infect Dis       Date:  2006-03-20       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.